Johnson & Johnson Ends Overseas Sales Of Acid Reflux Device Citing Market Factors Johnson & Johnson Will Stop Overseas Sales Of Gerd Medication
I'm PortAI, I can summarize articles.
Johnson & Johnson JNJ is reportedly halting international sales of its Linx Reflux Management System, a device used to treat chronic acid reflux. In a letter to doctors dated September 17, the company stated that sales outside the U.S. will cease at the end of March.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments